News - BioPharm International

ADVERTISEMENT

News

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B

October 30, 2014

Pfizer's Trumenba is the first FDA-approved immunization against meningococcal disease for individuals 10-25 years old.

EMA: Extrapolation Across Indications for Biosimilars a Possibility

October 30, 2014

The final guidance explains some principles for developing biosimilars and establishes some rules about extrapolation across indications for various medical conditions.

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment

October 29, 2014

Bristol-Myers Squibb announced that they have reached an agreement with F-star Alpha, giving Squibb the exclusive option to acquire F-star's HER2-targeted breast and gastric cancer treatment.

Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million

October 28, 2014

The company receives backing to continue its work in research services, process development, and cGMP manufacturing activities.

Yale and Gilead Extend Sequencing Initiative

October 28, 2014

The Yale School of Medicine and Gilead will continue their research on cancer targets for a minimum of three additional years.

Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research

October 28, 2014

New research will focus on a superfamily of protein receptors linked to various diseases.

Novartis Sells Influenza Vaccine Business to CSL for $275 Million

October 27, 2014

The divestment will create the number two player in the global influenza vaccine industry.

Baxter Recalls Two Lots of IntraVia

October 27, 2014

Two lots of empty intravenous fluid bags were voluntarily recalled because of the presence of particulates.

Celgene and Sutro Partner on ADC Development

October 24, 2014

Celgene expands its oncology drug discovery and development portfolio through a new partnership with Sutro.

ADVERTISEMENT

ADVERTISEMENT

Click here